Empower your career - a female perspective
This session is powered by TOPX Network
30 May 2024 - Utrecht
In this session, each panelist will share a bit about their journey, from where they started to how they reached their current roles. After the introductions, we’ll dive deeper into their unique career paths. Our speakers will discuss the key lessons they've learned along the way and offer valuable advice for women looking to follow in their footsteps. Don’t miss this opportunity to learn from and connect with women who are making waves in the Life Sciences!
Speakers
Liesbeth Hof | Sr Director Project Management Office | AM-Pharma
Liesbeth Hof has a Master in Medical Biology with over 20 years of international experiences in the pharmaceutical and biotech industry. During the very early phase of her career, she worked at the ministry of health, after which she moved to Novartis Global in Switzerland and later UK where she worked within global regulatory affairs. Following her time at big pharma she moved to the consultancy organisation ProPharma Group, where she managed a team of consultants and guided start-up and biotech companies in their development programs. Since 2022, she has been working with AM-Pharma, being responsible for the project management of the development programs and operational implementation. Over the years, Liesbeth drove diverse cross-functional global teams to deliver successful regulatory submissions within different therapeutic areas, including orphan drugs. She also led strategic planning and ensured achievement of major milestones at different stages of the product’s life cycle.
About AM-Pharma
AM-Pharma strives to develop medicines for patients confronted with severe medical conditions. Our proprietary asset, ilofotase alfa, is being developed for the treatment of patients with acute kidney injury (AKI) and has been granted FDA fast-track status. We also develop ilofotase alfa in the severe rare disease hypophosphatasia (HPP) where ilofotase alfa has orphan drug status in the US and EU. With more than 1,000 subjects evaluated to date in clinical trials, ilofotase alfa has a proven safety profile and a demonstrated kidney benefit in patients with acute kidney injury and has attenuated disease specific biomarkers in adult patients with hypophosphatasia. Currently, AM-pharma is conducting a Phase 2 trial in cardiac surgery-associated renal damage and preparing for a Phase 2/3 trial in HPP patients. We are a dedicated team driven to bring treatment options to severely ill patients, their families and acute care professionals.
Mireille Sanders | COO | Pharming
I hold an MSc in Chemical Engineering from the Technical University Eindhoven in the Netherlands. From 1996-2003 I had different (managerial) roles at Organon within Product Development both in the Netherlands as well as in the US. From 2004-2006 I was CMC lead for asenapine at Organon.
From 2007-2015, I was responsible for the Pilot Plant facility at Merck (and its predecessors). From 2016 until 2019, I served as Head of Clinical Supply Chain Strategic Management and Systems at Janssen Pharmaceuticals, a Johnson & Johnson company. In 2019 I joined Pharming Group N.V. as Sr VP Operations. Since December 2020 I am Chief Operations Officer (COO) at Pharming Group N.V. and responsible for preclinical research, product development, commercial manufacturing and supply chain.
About Pharming
Pharming is a global biopharmaceutical company developing and commercializing innovative protein replacement therapies and precision medicines to serve the unserved rare disease patient.Pharming's vision is to become the leading global rare disease company of choice with a specific focus on transformative medicines in rare diseases.Our mission is to bring the unserved rare disease patients the solutions they need through our fully integrated and ongoing drug development and commercialization expertise. Pharming creates long-term value by leveraging its core strengths in clinical development and rare-disease drug commercialization.
Cristina Martinez Muñoz | Sr. Director, Head of Manufacturing | Kite
Cristina Martinez Muñoz is a passionate and innovative leader with 15+ years of pharmaceutical experience in the industry, as well as 7 years of research experience.
Currently she is Senior Director of Cell Therapy Manufacturing at Kite.
Cristina is leading an organization of around 500 employees, mainly consisting of Cell Therapy Specialists, Team leads, and Associate Directors.
She is keen to add value to the organization solving business challenges, to connect people and to deliver results. Additionally, she is passionate about creating an inclusive, safe and open culture where people are empowered to build on each other’s ideas, collaborate and make decisions to bring the business to the next level. Her drive is to coach and mentor leaders while ensuring that female talent get the right level of exposure and development opportunities to advance in their careers, as well as creating a culture where employees feel heard and involved.
Early this year, Cristina was the winner of the TOPX Females to Follow Awards 2024, in the category of Industry.
Cristina Martinez Muñoz | Sr. Director, Head of Manufacturing | Kite
Cristina Martinez Muñoz is a passionate and innovative leader with 15+ years of pharmaceutical experience in the industry, as well as 7 years of research experience.
Currently she is Senior Director of Cell Therapy Manufacturing at Kite.
Cristina is leading an organization of around 500 employees, mainly consisting of Cell Therapy Specialists, Team leads, and Associate Directors.
She is keen to add value to the organization solving business challenges, to connect people and to deliver results. Additionally, she is passionate about creating an inclusive, safe and open culture where people are empowered to build on each other’s ideas, collaborate and make decisions to bring the business to the next level. Her drive is to coach and mentor leaders while ensuring that female talent get the right level of exposure and development opportunities to advance in their careers, as well as creating a culture where employees feel heard and involved.
Early this year, Cristina was the winner of the TOPX Females to Follow Awards 2024, in the category of Industry.
Moderator
Alex Cloherty | Award-winning science communicator and Marcomm | BioLizard
Dr. Alex Cloherty is an award-winning science
communicator, an enthusiastic speaker and event moderator, and responsible for
marcomm at the leading multi-national data analytics and data management
consulting company BioLizard. As the writer and creator of "Microbial
Mondays", a blog that aims to improve public understanding of
microbiology, Alex has published over a hundred articles and award-winning
short videos that explain biological concepts in jargon-free language. Alex is
also active in science communication and empowering women in science through
leading workshops on science communication, moderating live and online events,
and contributing articles to the BCF Career online platform. In her spare time,
Alex is an avid cyclist and is passionate about sustainable fashion. Alex is
proud to be a junior ambassador for the TOPX network.
Alex Cloherty | Award-winning science communicator and Marcomm | BioLizard
Dr. Alex Cloherty is an award-winning science
communicator, an enthusiastic speaker and event moderator, and responsible for
marcomm at the leading multi-national data analytics and data management
consulting company BioLizard. As the writer and creator of "Microbial
Mondays", a blog that aims to improve public understanding of
microbiology, Alex has published over a hundred articles and award-winning
short videos that explain biological concepts in jargon-free language. Alex is
also active in science communication and empowering women in science through
leading workshops on science communication, moderating live and online events,
and contributing articles to the BCF Career online platform. In her spare time,
Alex is an avid cyclist and is passionate about sustainable fashion. Alex is
proud to be a junior ambassador for the TOPX network.
This session is powered by:
| For job seekers | For employers | Join BCF Career Event |
| | Register BCF BE | |
| Powered by: Hyphen Projects Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 |
© Copyright 2024 by Hyphen Projects